Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53
AUTOR(ES)
Ohiro, Yoichi
FONTE
American Society for Microbiology
RESUMO
More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not well defined. Some p53 mutants, but not wild-type p53, are shown here to interact with Daxx, a Fas-binding protein that activates stress-inducible kinase pathways. Interaction of Daxx with p53 is highly dependent upon the specific mutation of p53. Tumorigenic mutants of p53 bind to Daxx and inhibit Daxx-dependent activation of the apoptosis signal-regulating kinase 1 stress-inducible kinases and Jun NH2-terminal kinase. Mutant p53 forms complexes with Daxx in cells, and consequently, mutant p53 is able to rescue cells from Daxx-dependent inhibition of proliferation. Thus, the accumulation of mutant p53 in tumor cells may contribute to tumorigenesis by inhibiting stress-inducible kinase pathways.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=140653Documentos Relacionados
- Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression.
- Stress-Inducible Cellular Responses
- Molecular Characterization of a Stress-Inducible Gene from Lactobacillus helveticus
- Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA.
- CHOP-Dependent Stress-Inducible Expression of a Novel Form of Carbonic Anhydrase VI
